Market Overview

Goldman Says FDA Response to Energy Drink Safety Review 'Encouraging' for Monster

Share:
Related MNST
Monster Beverage's $2 Billion Question
Calls Of Note: Wall Street Research Moving The Market On Thursday
Monster Or WhiteWave: Choose Based On Growth Prospects (Seeking Alpha)

Commenting on the action in Monster Beverage this afternoon, Goldman Sachs analyst Judy Hong called the FDA's response to the energy drink safety issue "generally benign." Hong believes this should be encouraging for Monster. The analyst believes the most likely outcome related to Durbin's energy drink review will be strong labeling, something which is unlikely to have a material impact on Monster.

Latest Ratings for MNST

DateFirmActionFromTo
Aug 2015Morgan StanleyUpgradesEqual-weightOverweight
Aug 2015BMO CapitalMaintainsOutperform
Aug 2015CitigroupMaintainsBuy

View More Analyst Ratings for MNST
View the Latest Analyst Ratings

Posted-In: Analyst Color Analyst Ratings Movers

 

Related Articles (MNST)

View Comments and Join the Discussion!

Get Benzinga's Newsletters